atrial fibrillation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Between 18 and 75 years old (including 18 and 75 years old), regardless of gender; 2.Patients with clinical definite diagnosis of atrial fibrillation; 3.The subjects understood the test process and voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Left ventricular ejection fraction (LVEF) = 40%; 2.Cardiac function: NYHA class ? - ?; 3.Previous unsuccessful radiofrequency ablation or recurrent cases; 4.Pregnant and lactating women and those who plan to become pregnant within one year; 5.Those with obvious bleeding tendency or suffering from blood system diseases and unable to tolerate anticoagulant drugs; 6.Acute or severe systemic infection, clinically significant severe liver and kidney dysfunction, uncontrolled hyperthyroidism Or patients with malignant tumors and end-stage diseases; 7.Before operation, it was confirmed that there were many types of tachyarrhythmias; 8.Severe organic cardiovascular disease; 9.Stroke and other cerebrovascular diseases in recent 3 months, 10.Thromboembolic disease; 11.Patients with mental abnormality or history of mental illness who cannot cooperate autonomously, and patients with history of epilepsy; 12.Severe allergic constitution; 13.Those who have participated in clinical trials of any drugs and / or medical devices within 1 month before enrollment; 14.The researchers believe that there are any other factors that are not suitable for inclusion or affect the subjects' participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immediate success rate: pulmonary vein isolation after ablation;ECG; | — |
Countries
China